Results 81 to 90 of about 46,120 (196)

Controlled release floating multiparticulates of metoprolol succinate by hot melt extrusion [PDF]

open access: yes, 2015
YesWe present hot melt extrusion (HME) for the design of floating multiparticulates. Metoprolol succinate was selected as the model drug. Our foremost objective was to optimize the components Eudragit® RS PO, polyethylene oxide (PEO) and hydroxypropyl ...
Paradkar, Anant R   +2 more
core   +1 more source

DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF METOPROLOL SUCCINATE AND CILNIDIPINE IN BULK AND PHARMACEUTICAL DOSAGE FORM [PDF]

open access: yes, 2015
Objective: Development and validation of stability indicating RP-HPLC method for the simultaneous estimation of Metoprolol succinate and Cilnidipine in bulk and pharmaceutical dosage form.Methods: The separation was carried out on STD Kromasil 150 C18 (4.
Janeyulu, Immadisetty Srikrishnan   +3 more
core   +1 more source

Hot melt extrusion assisted additive manufacturing of mixed polymeric 3D printed metoprolol succinate extended-release tablets for controlled oral drug delivery

open access: yesChemical Physics Impact
This study introduces an innovative methodology for fabricating extended-release metoprolol succinate (MS) tablets through the integration of Soluplus® and hydroxypropyl methylcellulose acetate succinate (HPMCAS) polymers, employing hot-melt extrusion ...
Shubham Ghatole   +5 more
doaj   +1 more source

Formulation and Evaluation of Extended Release Metoprolol Succinate Matrix Tablets. [PDF]

open access: yes, 2013
Treatment of acute diseases or chronic illnesses have been mostly accomplished by delivery of drugs to patients using various pharmaceutical dosage forms including tablets, capsules, suppositories, creams, ointments, liquids, aerosols and injectables ...
Ramya, Y
core  

FORMULATION AND EVALUATION OF METOPROLOL SUCCINATE EXTENDED RELEASE TABLETS COMPRISING COATED PELLETS

open access: yes, 2019
The objective of the present study was for improving bioavailability and reducing the dosage frequency of Metoprolol succinate in the form of extended release pellets by pan coating technology. Preliminary studies with different polymers such as Surelase,
V. Madhu Sudarsan*, S.T.V. Raghavamma, N. Rama Rao
core   +1 more source

Metoprolol tartrate and succinate: from chemical structure to clinical effectiveness differences

open access: yesРоссийский кардиологический журнал, 2007
.
Yu. B. Belousov   +2 more
doaj  

Optimization of screw design for continuous wet granulation: A case study of metoprolol succinate ER tablets. [PDF]

open access: yesInt J Pharm, 2022
Zidan A   +4 more
europepmc   +1 more source

Switching from batch to continuous granulation: A case study of metoprolol succinate ER tablets. [PDF]

open access: yesInt J Pharm, 2022
Kotamarthy L   +7 more
europepmc   +1 more source

Pharmacokinetic considerations of formulation: extended-release metoprolol succinate in the treatment of heart failure

open access: yes, 2003
Extended-release (ER) metoprolol succinate is a controlled-release formulation designed to deliver metoprolol succinate at a near constant rate for approximately 20 h, independent of food intake and gastrointestinal pH. Once-daily dosing of ER metoprolol
Stanbrook, Hilary   +4 more
core  

Home - About - Disclaimer - Privacy